A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix®) with corresponding monovalent vaccines (Havrix® and Engerix-B®) in adults
- 29 August 2001
- Vol. 19 (32), 4710-4719
- https://doi.org/10.1016/s0264-410x(01)00240-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Long‐term persistence of antibodies induced by vaccination and safety follow‐up, with the first combined vaccine against hepatitis A and B in children and adults*Journal of Medical Virology, 2001
- Antibody production in response to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.The Journal of Infectious Diseases, 2000
- Rationale for the infant and adolescent vaccination programmes in Italy.Vaccine, 2000
- Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccinesVaccine, 2000
- Interference of Antibody Production to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B VaccineThe Journal of Infectious Diseases, 1999
- A two dose combined hepatitis A and B vaccine in Chinese youngstersJournal of Medical Virology, 1999
- The first combined vaccine against hepatitis A and B: an overviewVaccine, 1999
- Hepatitis A vaccine for Israeli childrenThe Lancet, 1998
- Safety and Immunogenicity of a Combined Hepatitis A and Hepatitis B Vaccine in Young Healthy AdultsScandinavian Journal of Gastroenterology, 1996
- Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccineJournal of Medical Virology, 1994